Mounjaro Approved for Weight Loss
Summary Mounjaro, a dual-action GIP and GLP-1 receptor agonist, gains FDA approval for chronic weight management in adults with obesity or overweight and a weight-related condition. This marks a significant advancement in addressing the obesity […]
